205
Participants
Start Date
March 31, 2016
Primary Completion Date
August 22, 2019
Study Completion Date
August 22, 2019
Pipeline™ Flex Embolization Device with Shield Technology™
"Pipeline™ Flex Embolization Device with Shield Technology™ utilizes a phosphorylcholine (PC) surface treatment to the implant combined with the PFED delivery system. The Shield Technology™ surface treatment applied to the implant is an inert polymer material created to mimic the outer membrane of a human red blood cell.~The Pipeline™ Flex Embolization Device with Shield Technology™ is intended for endovascular embolization of cerebral aneurysms and is designed to be placed across the opening (or 'neck') of a brain aneurysm and redirect blood flow away from the aneurysm, causing the blood within the aneurysm to clot."
Rigshospitalet, Copenhagen
Hospital Fundación Jiménez Díaz, Madrid
Gold Coast University Hospital, Southport
Turun Yliopistollinen keskussairaala, Turku
Hôpital Bicêtre, Le Kremlin-Bicêtre
Universitätsklinikum Augsburg, Augsburg
Charité Centrum, Berlin
Alfried Krupp Krankenhaus, Essen
Universitätsklinikums Heidelberg, Heidelberg
Universitätsklinikum des Saarlandes, Homburg
Hellenic Airforce Hospital, Athens
Országos Klinikai Idegtudományi Intézet, Budapest
Hadassah Medical Organization, Jerusalem
Ospedale M. Bufalini, Cesena
Istituto Neurologico Carlo Besta, Milan
Hospital Universitario Cruces, Barakaldo
Hospital Universitario de la Princesa, Madrid
Hospital Universitario Puerta de Hierro, Madrid
Hospital Universitario Central de Asturias, Oviedo
Royal Preston Hospital, Preston
Queen Elizabeth Hospital, Birmingham
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Medtronic Neurovascular Clinical Affairs
INDUSTRY